Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 3
2019 1
2020 2
2021 5
2022 2
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
New Treatments for Recurrent Uterine Cancer.
Toboni MD, Powell MA. Toboni MD, et al. Curr Oncol Rep. 2021 Nov 4;23(12):139. doi: 10.1007/s11912-021-01129-4. Curr Oncol Rep. 2021. PMID: 34735648 Review.
Uterine carcinosarcomas: From pathology to practice.
Toboni MD, Crane EK, Brown J, Shushkevich A, Chiang S, Slomovitz BM, Levine DA, Dowdy SC, Klopp A, Powell MA, Thaker PH. Toboni MD, et al. Gynecol Oncol. 2021 Jul;162(1):235-241. doi: 10.1016/j.ygyno.2021.05.003. Epub 2021 May 21. Gynecol Oncol. 2021. PMID: 34030871 Review.
State of the science: Uterine sarcomas: From pathology to practice.
Shushkevich A, Thaker PH, Littell RD, Shah NA, Chiang S, Thornton K, Hensley ML, Slomovitz BM, Holcomb KM, Leitao MM, Toboni MD, Powell MA, Levine DA, Dowdy SC, Klopp A, Brown J. Shushkevich A, et al. Among authors: toboni md. Gynecol Oncol. 2020 Oct;159(1):3-7. doi: 10.1016/j.ygyno.2020.08.008. Epub 2020 Aug 21. Gynecol Oncol. 2020. PMID: 32839026 No abstract available.
GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress.
Mullen MM, Lomonosova E, Toboni MD, Oplt A, Cybulla E, Blachut B, Zhao P, Noia H, Wilke D, Rankin EB, Kuroki LM, Hagemann AR, Hagemann IS, McCourt CK, Thaker PH, Mutch DG, Powell MA, Mosammaparast N, Vindigni A, Fuh KC. Mullen MM, et al. Among authors: toboni md. Mol Cancer Res. 2022 Feb;20(2):265-279. doi: 10.1158/1541-7786.MCR-21-0302. Epub 2021 Oct 20. Mol Cancer Res. 2022. PMID: 34670865 Free PMC article.
Differential responses to immune checkpoint inhibitors are governed by diverse mismatch repair gene alterations.
Khushman MM, Toboni MD, Xiu J, Manne U, Farrell A, Lou E, Shields AF, Philip PA, Salem ME, Abraham J, Spetzler D, Marshall J, Jayachandran P, Hall MJ, Lenz HJ, Sahin IH, Seeber A, Powell MA. Khushman MM, et al. Among authors: toboni md. Clin Cancer Res. 2024 Feb 13. doi: 10.1158/1078-0432.CCR-23-3004. Online ahead of print. Clin Cancer Res. 2024. PMID: 38350001
Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer.
Toboni MD, Lomonosova E, Bruce SF, Tankou JI, Mullen MM, Schab A, Oplt A, Noia H, Wilke D, Kuroki LM, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Khabele D, Mutch DG, Fuh KC. Toboni MD, et al. Cancers (Basel). 2021 Nov 23;13(23):5877. doi: 10.3390/cancers13235877. Cancers (Basel). 2021. PMID: 34884986 Free PMC article.
Radiation therapy for vaginal and perirectal lesions in recurrent ovarian cancer.
Johns EA, Stanley JA, Toboni MD, Schwarz JK, Zhang F, Hagemann AR, Fuh KC, Thaker PH, McCourt CK, Mutch DG, Powell MA, Khabele D, Kuroki LM. Johns EA, et al. Among authors: toboni md. Gynecol Oncol Rep. 2021 Jun 9;37:100808. doi: 10.1016/j.gore.2021.100808. eCollection 2021 Aug. Gynecol Oncol Rep. 2021. PMID: 34169134 Free PMC article.
16 results